Get notified when PHGE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Related Party (new) — Mandragola financed BiomX's acquisition of a controlling stake in DFSL, indicating a related-party relationship with potential conflicts of interest.
BiomX converts $379k debt to 1M shares, taps $2M credit line with related-party lender
Filed June 5, 2026 · Period ending June 2, 2026 · ~1 min read
Key Changes
-
high
BiomX issued 1,013,637 shares (10% dilution) to convert ~$379k of debt from Mandragola, a related-party lender. Outstanding shares now total 11.16 million.
Item 3.02 verify on EDGAR → -
high
Company has access to $2M revolving credit facility from Mandragola at 12% interest. Advances convert to stock at prior day's closing price, creating ongoing dilution risk.
Item 3.02 verify on EDGAR → -
high
BiomX issued Mandragola a 5-year warrant for 2 million shares at $12.00 per share, pending stockholder approval. If exercised, would represent 18% additional dilution.
Item 3.02 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.
Partner
Trade PHGE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify